26 related articles for article (PubMed ID: 21089675)
1. Oncolytic vaccinia virus as a vector for therapeutic sodium iodide symporter gene therapy in prostate cancer.
Mansfield DC; Kyula JN; Rosenfelder N; Chao-Chu J; Kramer-Marek G; Khan AA; Roulstone V; McLaughlin M; Melcher AA; Vile RG; Pandha HS; Khoo V; Harrington KJ
Gene Ther; 2016 Apr; 23(4):357-68. PubMed ID: 26814609
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer.
Barton KN; Stricker H; Elshaikh MA; Pegg J; Cheng J; Zhang Y; Karvelis KC; Lu M; Movsas B; Freytag SO
Mol Ther; 2011 Jul; 19(7):1353-9. PubMed ID: 21587209
[TBL] [Abstract][Full Text] [Related]
3. Improved radioiodine-131 imaging of prostatic carcinoma using the sodium iodide symporter gene under control of the survivin promoter.
Zhao Z; Huang R; Cai H; Liu B; Zeng Y; Kuang A
Int J Clin Exp Pathol; 2018; 11(8):4067-4072. PubMed ID: 31949797
[TBL] [Abstract][Full Text] [Related]
4. Efficient multicistronic co-expression of hNIS and hTPO in prostate cancer cells for nonthyroidal tumor radioiodine therapy.
Li G; Xiang L; Yang W; Wang Z; Wang J; Chen K
Am J Nucl Med Mol Imaging; 2012; 2(4):483-98. PubMed ID: 23145364
[TBL] [Abstract][Full Text] [Related]
5. Probasin promoter (ARR(2)PB)-driven, prostate-specific expression of the human sodium iodide symporter (h-NIS) for targeted radioiodine therapy of prostate cancer.
Kakinuma H; Bergert ER; Spitzweg C; Cheville JC; Lieber MM; Morris JC
Cancer Res; 2003 Nov; 63(22):7840-4. PubMed ID: 14633711
[TBL] [Abstract][Full Text] [Related]
6. Targeting of tumor radioiodine therapy by expression of the sodium iodide symporter under control of the survivin promoter.
Huang R; Zhao Z; Ma X; Li S; Gong R; Kuang A
Cancer Gene Ther; 2011 Feb; 18(2):144-52. PubMed ID: 21037556
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine therapy for castration-resistant prostate cancer following prostate-specific membrane antigen promoter-mediated transfer of the human sodium iodide symporter.
Gao XF; Zhou T; Chen GH; Xu CL; Ding YL; Sun YH
Asian J Androl; 2014; 16(1):120-3. PubMed ID: 24369144
[TBL] [Abstract][Full Text] [Related]
8. Glial fibrillary acidic protein promoters direct adenovirus early 1A gene and human telomerase reverse transcriptase promoters direct sodium iodide symporter expression for malignant glioma radioiodine therapy.
Li W; Tan J; Wang P; Li N; Li C
Mol Cell Biochem; 2015 Jan; 399(1-2):279-89. PubMed ID: 25410753
[TBL] [Abstract][Full Text] [Related]
9. Treatment of prostate cancer by radioiodine therapy after tissue-specific expression of the sodium iodide symporter.
Spitzweg C; O'Connor MK; Bergert ER; Tindall DJ; Young CY; Morris JC
Cancer Res; 2000 Nov; 60(22):6526-30. PubMed ID: 11103823
[TBL] [Abstract][Full Text] [Related]
10. [Radioiodide treatment mediated by adenovirus transfer of human sodium iodide symporter gene into androgen-independent prostate cancer].
Huang R; Ma X; Li S; Mu D; Gong R; Kuang A
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Oct; 27(5):1080-4. PubMed ID: 21089675
[TBL] [Abstract][Full Text] [Related]
11. A transporter gene (sodium iodide symporter) for dual purposes in gene therapy: imaging and therapy.
Cho JY
Curr Gene Ther; 2002 Dec; 2(4):393-402. PubMed ID: 12477251
[TBL] [Abstract][Full Text] [Related]
12. Approaches to gene therapy with sodium/iodide symporter.
Spitzweg C; Morris JC
Exp Clin Endocrinol Diabetes; 2001; 109(1):56-9. PubMed ID: 11573142
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
